Myositis in children

Current Opinion in Rheumatology

Volumn 13, Issue 5, 2001, Pages 428-433

  Reed, Ann M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICAINE; AZATHIOPRINE; BCG VACCINE; CORTICOSTEROID; CYCLOSPORIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; METHOTREXATE; PENICILLAMINE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

CHILD; CHILDHOOD DISEASE; CHIMERA; DIAGNOSTIC APPROACH ROUTE; DRUG INDUCED DISEASE; ENVIRONMENTAL FACTOR; HUMAN; IDIOPATHIC DISEASE; IMMUNE RESPONSE; JUVENILE DERMATOMYOSITIS; MYOSITIS; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MYOSITIS;

EID: 0034816498     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200109000-00015     Document Type: Review

References (60)

1. The incidence of juvenile dermatomyositis: Results from a nation-wide study
2. Inflammatory myositis in children, including differential diagnosis
3. Classifications and treatment of juvenile idiopathic inflammatory myopathies
4. Echovirus polymyositis in patients with hypogammaglobulinemia: Failure of high-dose intravenous gammaglobulin therapy and review of the literature
5. Dermatomyositis, polymyositis, and Coxsackie B virus infection
6. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis
7. Absence of Coxsackie virus in idiopathic inflammatory muscle disease by in situ hybridization
8. X-Linked A gammaglobulinemia: An analysis of 96 patients
9. Chronic enteroviral meningoencephalitis in agammaglobulemic patients
10. Lack of detection of enterovirus RNA or bacterial DNA in MR imaging: Directed muscle biopsies from 20 children with active untreated juvenile dermatomyositis
11. Juvenile dermatomyositis in a child infected with human parvovirus B19
12. Acute hepatitis B stimulating dermatomyositis
13. Streptococcal myositis as a complication of juvenile dermatomyositis
14. Childhood polymyositis, a case controlled study
15. Recurrent juvenile dermatomyositis in cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human muscle myosin
16. Dermatomyositis associated with Lyme disease: Case report and review of Lyme myositis
17. Orbital myositis with Lyme disease
18. Familial recurrence of dermatomyositis and progressive scleroderma after injection of a local anesthetic for dental treatment
19. D·penicillamine-induced polymyositis in juvenile chronic arthritis: Report of case
20. Dermatomyositis after BCG vaccination
21. Vasculitis and myositis secondary to rubella vaccine
22. Dermatomyositis and vaccination
23. Dermatomyositis after immunization
24. Demographic and clinical features of patients who develop myositis following immunization
25. Myalgias and elevated creatine kinase activity associated with subcutaneous injection of diluent
26. Myositis associated with growth hormone therapy
27. Geographic clustering of juvenile dermatomyositis (JDM) subjects
28. Geographic and environmental exposures in the development of juvenile dermatomyositis
29. Epidemiologic features and environmental exposures associated with illness, onset in juvenile idiopathic inflammatory myopathy
30. Polymyositis as a manifestation of chronic graft vs host disease
31. Neuromuscular complications of bone marrow transplant
32. Polymyositis in chronic graft vs host disease, a case report
33. Chimerism in children with juvenile dermatomyositis
34. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies
35. The HLA-DQA1*0501 allele in juvenile dermatomyositis as seen in multiple racial groups
36. The lack of CLIP association with HLADQA1501 allele and association with juvenile dermatomyositis
37. Analysis of HLA-DM polymorphisms in juvenile dermatomyositis (JDMS)
38. Muscle biopsy findings in 38 untreated children with juvenile dermatomyositis: Capillary occlusion is associated with TNF 2 allele
39. The TNF A 2 allele (AA, GA) is associated with calcinosis, a chronic disease course and increased in vitro production of TNF-alpha but not TGF-beta by peripheral blood mononuclear cells from children with juvenile dermatomyositis
40. Polymorphisms in the IL-1 receptor antagonist gene VNTR or possible risk factors for juvenile idiopathic inflammatory myopathy
41. Studies of muscle biopsy from DQA1*0501 untreated children with juvenile dermatomyositis very early in disease course: Evidence of a TCR Vβ8 motif and increased CD56+NK cells
42. Polymorphisms in cytokine genes are associated with juvenile idiopathic inflammatory myopathy
43. Correlations between change and disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomyositis
44. BCL-2, p 53 c-nyc expression in juvenile dermatomyositis
45. Decreased levels of CD54 (ICAM·1) positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis
46. Muscle abnormalities in juvenile dermatomyositis patients
47. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis
48. Scintigraphic evaluation of calcinosis in juvenile dermatomyositis with Tc-99m MDP
49. Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate
50. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
51. Therapeutic use of an extemporaneously prepared oral suspension o1 tacrolimus in pediatric patients
52. FK-506 in the treatment of unresponsive juvenile dermatomyositis
53. Autologous hemopoetic stem cell transplant for children with refractory autoimmune disease
54. The safety of resistant home exercise program in patients with recent onset active polymyositis and dermatomyositis
55. An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem
56. Treatment of calcinosis with diltiazem
57. Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling
58. Classification and treatment of juvenile idiopathic inflammatory
59. Update on the genetics of idiopathic inflammatory myopathies
60. A patient of infantile polymyositis triggered by respiratory syncytial virus infection